• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR RX HERCULINK ELITE STENT SYSTEM; STENT, RENAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR RX HERCULINK ELITE STENT SYSTEM; STENT, RENAL Back to Search Results
Model Number 1011493-12
Device Problems Difficult to Remove (1528); Material Separation (1562); Failure to Advance (2524)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/04/2022
Event Type  malfunction  
Event Description
It was reported that the procedure was performed to treat a lesion in the 100% occluded ostial superior mesenteric artery (sma).The herculink elite stent delivery system was advanced over a long spartacore guide wire.No issues were noted during advancement with the guide wire, but difficulty was noted advancing the herculink elite due to the patient anatomy, so removal of the device was initiated; however, during removal, resistance was noted with the guide wire.The device was pulled and the herculink elite stent delivery separated at a location outside the patient anatomy.After removing the proximal device, the proximal guide wire was cut to remove the herculink elite separated segment.The procedure continued using the same cut guide wire.A second herculink elite was then implanted without issue.There was no adverse patient effect and no clinically significant delay.No additional information was provided.
 
Manufacturer Narrative
The device was received.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.The spartacore guide wire mentioned is filed under a separate medwatch mfr report number.
 
Manufacturer Narrative
A visual and dimensional inspection was performed on the returned device.The reported material separation and difficult to remove from the guide wire was confirmed.The reported failure to advance could not be tested as it was based on operational circumstances.Additionally, the balloon was noted to be bunched and wrinkled and the inner member was noted to be bunched and stretched.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents.There was no damage noted to the stent delivery system (sds) during the inspection prior to use which suggests a product quality issue did not contribute to the reported difficulties.In this case, it is likely the device interacted with the 100% stenosed lesion during advancement causing the reported failure to advance, noted bunched balloon, and bunched inner member.A buildup of procedural contaminants likely contributed to the reported difficult to remove (guide wire resistance), causing the noted wrinkled balloon.Further interaction with the procedural contaminates while attempting to retract the device over the guide wire likely contributed to the reported difficult to remove and noted stretched inner member, ultimately causing the reported material separation (shaft) and noted separation of the proximal seal.The investigation determined the reported difficulties appear to be related to circumstances of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RX HERCULINK ELITE STENT SYSTEM
Type of Device
STENT, RENAL
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key13609361
MDR Text Key287586078
Report Number2024168-2022-02041
Device Sequence Number1
Product Code NIN
UDI-Device Identifier08717648078002
UDI-Public08717648078002
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/30/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/26/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number1011493-12
Device Catalogue Number1011493-12
Device Lot Number1052061
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/11/2022
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/07/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/20/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
HI-TORQUE SPARTACORE GUIDE WIRE.
Patient Age81 YR
Patient SexFemale
-
-